2016 ◽  
Vol 55 (04) ◽  
pp. 145-150 ◽  
Author(s):  
Lutz Freudenberg ◽  
Hinrich Wieder ◽  
Jens Stollfuss

SummaryAim: The precise localisation of osteoarthritic and inflammatory changes is crucial for selective treatment planning of radiosynovectomy (RSV). The present study evaluated the diagnostic accuracy of planar bone imaging and SPECT for the detection of pathological bone metabolism and inflammation in joints of the foot and ankle, compared with SPECT/CT. Patients, methods: 39 patients (mean age 65.6 ± 11.1 years) with suspected inflammatory osteoarthritis underwent SPECT/CT of the feet. After injection of approximately 500 MBq 99mTc DPD, all patients had three-phase planar bone imaging and late-phase hybrid SPECT/CT. late-phase SPECT, and CT of the foot. Increased bone metabolism and blood-pool was assigned to the respective joint of the fore-, mid-, and hindfoot, using SPECT/CT as the reference standard. Results: Overall, SPECT had a higher sensitivity than planar imaging (0.80 vs 0.68, n.s.). The advantage of SPECT was most obvious in the anatomically complex midfoot area (0.63 vs 0.26, p < 0.05) and less obvious in the forefoot (0.85 vs 0.79, n.s.) and hindfoot (0.89 vs 0.89, n.s.). The overall concordance (Cohen`s Kappa) between SPECT/CT and planar (late-phase) imaging and SPECT was high for the forefoot and the hindfoot (planar: 0.78/0.81; SPECT 0.86/0.88) and comparatively low for the midfoot (planar: 0.27; SPECT 0.61). Conclusion: SPECT was significantly superior to planar bone imaging for the detection of joint lesions in the midfoot. The differences between SPECT and planar imaging in the fore- and hindfoot were not significant, most likely due to the inherently less complex anatomy. Compared with SPECT alone, a benefit from the use of SPECT/CT can be observed in the midfoot region where it facilitates the identification of the correct joint for RSV.


Author(s):  
Nara Caroline Pereira ◽  
Juliana de Oliveira Silva ◽  
Frederico B. De Sousa ◽  
Sued Eustáquio Mendes Miranda ◽  
Daniel Crístian Ferreira Soares ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Akito Morimoto ◽  
Junichi Kikuta ◽  
Keizo Nishikawa ◽  
Takao Sudo ◽  
Maki Uenaka ◽  
...  

AbstractOsteoclastic bone resorption and osteoblastic bone formation/replenishment are closely coupled in bone metabolism. Anabolic parathyroid hormone (PTH), which is commonly used for treating osteoporosis, shifts the balance from osteoclastic to osteoblastic, although it is unclear how these cells are coordinately regulated by PTH. Here, we identify a serine protease inhibitor, secretory leukocyte protease inhibitor (SLPI), as a critical mediator that is involved in the PTH-mediated shift to the osteoblastic phase. Slpi is highly upregulated in osteoblasts by PTH, while genetic ablation of Slpi severely impairs PTH-induced bone formation. Slpi induction in osteoblasts enhances its differentiation, and increases osteoblast–osteoclast contact, thereby suppressing osteoclastic function. Intravital bone imaging reveals that the PTH-mediated association between osteoblasts and osteoclasts is disrupted in the absence of SLPI. Collectively, these results demonstrate that SLPI regulates the communication between osteoblasts and osteoclasts to promote PTH-induced bone anabolism.


1976 ◽  
Vol 1 (1) ◽  
pp. 18-25 ◽  
Author(s):  
KINICHI HISADA ◽  
YUTAKA SUZUKI ◽  
MATARO IIMORI
Keyword(s):  

2001 ◽  
Vol 121 (5) ◽  
pp. 632-636 ◽  
Author(s):  
R. Klingebiel ◽  
H.-C. Bauknecht ◽  
P. Rogalla ◽  
U. Bockmühl ◽  
O. Kaschke ◽  
...  

2018 ◽  
Vol 25 (2) ◽  
pp. 652-662 ◽  
Author(s):  
Ulka N. Vaishampayan ◽  
Izabela Podgorski ◽  
Lance K. Heilbrun ◽  
Jawana M. Lawhorn-Crews ◽  
Kimberlee C. Dobson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document